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Abstract
Background: Recently, there have been a number of studies on the association between XRCC1 polymorphisms and
childhood acute lymphoblastic leukemia (ALL) risk. However, the results of previous reports are inconsistent. Thus, we
performed a meta-analysis to clarify the effects of XRCC1 variants on childhood ALL risk.
Methods: A meta-analysis was performed to examine the association between XRCC1 polymorphisms (Arg399Gln,
Arg194Trp, and Arg280His) and childhood ALL risk. We critically reviewed 7 studies with a total of 880 cases and 1311
controls for Arg399Gln polymorphism, 3 studies with a total of 345 cases and 554 controls for Arg280His polymorphism, and
6 studies with a total of 783 cases and 1180 controls for Arg194Trp polymorphism, respectively. Odds ratio (OR) and its 95%
confidence interval (CI) were used.
Results: Significant association between XRCC1 Arg399Gln polymorphism and childhood ALL risk was observed in total
population analyses (ORadditive model=1.501, 95% CI 1.112–2.026, POR=0.008; ORdominant model=1.316, 95% CI=1.104–1.569,
POR=0.002) and Asian subgroup analyses (ORadditive model=2.338, 95%CI=1.254–4.359, POR=0.008; ORdominant model=2.108,
95%CI=1.498–2.967, POR=0.000). No association was detected in Caucasians, Metizo and mixed populations. Ethnicity was
considered as a significant source of heterogeneity in the meta-regression model. For the other two XRCC1 polymorphisms,
no association with childhood ALL risk was found.
Conclusions: The meta-analysis results suggested that XRCC1 Arg399Gln polymorphism might be associated with elevated
childhood ALL risk among Asian population.
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Introduction
While survival rates for childhood acute lymphoblastic leukemia
(ALL) have been improved significantly over the past 50 years,
ALL is still the most common pediatric cancer in developed
countries with high incidence and mortality [1].
As a complex and multifactorial process, leukemogenesis is still
not fully understood. It is widely known that dysregulated immune
response to infection may be a cause of childhood ALL [2].
Although the role of environmental exposure is still currently
undefined, it is likely that the environmental carcinogenesis
exposure is influenced by co-inheritance of multiple low-risk
variants, such as single nucleotide polymorphisms (SNPs) in
susceptible genes [3]. These variants can be identified by
comparing the frequency of polymorphic genotypes in cases and
controls.
To date, the candidates for childhood ALL susceptibility genes
have been categorized into those coding for carcinogen metabo-
lism enzymes, folate metabolism enzymes, DNA repair proteins,
and others [4]. The DNA repair system plays an important role in
maintaining the genome integrity and stability through the
reversal of DNA damage. If accumulated mutations are occurred
in corresponding DNA repair genes, their reversal capacity could
be damaged, substantially increasing the risk of cancer. SNPs in
common DNA repair genes have been identified and demonstrat-
ed to be linked to several sporadic carcinogenesis [5,6].
X-ray repair cross-complementing group 1 (XRCC1), located on
chromosome 19q13.2–13.3, with 33 kilobases in length, is one of
the most important proteins in base excision repair (BER) [7].
BER is also the predominant DNA damage repair pathway for the
processing of small base lesions derived from oxidation and
alkylation damage [8]. There have been more than 300 validated
SNPs in the XRCC1 gene reported in the dbSNP database (http://
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e34897www.ncbi.nlm.nih.gov/SNP). Nevertheless, only three genetic
changes have been extensively studied including Arg194Trp on
exon 6 (rs1799782 in dbSNP, C/T), Arg280His on exon 9
(rs25489 in dbSNP, G/A), and Arg399Gln on exon 10 (rs25487 in
dbSNP, G/A). There have been a number of studies on the
association between XRCC1 polymorphisms and childhood ALL
risk [9–15]. However, these inconsistent results fail to clarify this
complicated genetic relationship because of the small sample size
and its low statistical power. To reliably demonstrate the effect of
XRCC1 variants (Arg399Gln, Arg280His, and Arg194Trp) on
childhood ALL risk, we conduct a meta-analysis of all eligible
studies to resolve this pivotal issue.
Materials and Methods
Study identification and selection
Computer searches of PubMed, EMBASE, Medline, Google
Scholar and Cochrane Library were performed by two authors
independently using the following key words (‘‘childhood acute
lymphoblastic leukemia’’ or ’’childhood ALL’’)and(‘‘XRCC1’’ or
‘‘X-rayrepaircross-complementationgroup1’’),coveringallpapers
published before November 30, 2011. All eligible articles were
retrieved and their references were searched simultaneously to find
other relevant articles. Inclusion criteria was defined as follows: (1)
case-control studies evaluating the association between XRCC1
polymorphisms and childhood ALL risk; (2) studies based on
unrelated individuals; (3) sufficient published data available to
estimate an odds ratio (OR) with 95% confidence interval (CI). We
excluded studies that were not full-length publications articles or
letters in peer-reviewed English journals. When the same patient
populationwasincludedindifferentarticles,theonewiththelargest
population of participants or the most recent one was selected.
Data extraction
The following information was extracted from each study by
two authors independently: first author, publication year,
ethnicity, area, mean age of the study subjects, gender component,
matching criteria, genotyping method, numbers of cases and
controls, and genotype frequency of cases and controls. The two
authors achieved a consensus at last.
Statistical analysis
The strength of XRCC1 polymorphisms and childhood ALL risk
wasassessedbyoddsratios(ORs)withthecorresponding95%CIfor
each study. The OR and its 95% CI in each comparison were
assessed in additive (aa versus AA; a was for the minor allele and A
wasforthemajorallele),dominant(aa+AaversusAA),andrecessive
(aa versus Aa+AA) genetic models. Heterogeneity among studies
wastestedbychi-square-basedQtest,andI
2statisticswascalculated
toquantifytheproportionofthetotalvariationduetoheterogeneity
[16]. The pooled ORs were calculated by a fixed-effects model (the
Mantel-Haenszel method) when the P value.0.05 for the Q test
which indicated a lack of heterogeneity among the studies [17].
Otherwise, a random-effects model (DerSimonian-Laird method)
was used [18]. The source of heterogeneity was explored in a meta-
regression model. The significance of pooled ORs was determined
by Z test (P,0.05 was considered statistically significant). The
potential publication bias was examined visually in a funnel plot of
log[OR] against its standard error (SE), and the degree of
asymmetry was tested by Egger’s test (P,0.05 was considered a
significantpublicationbias)[19].Inthecontrolpopulations,Hardy–
Weinberg equilibrium (HWE) was tested. In addition, subgroup
analysis for ethnicity (Asian, Caucasian, Mestizo, and Mixed
population) was conducted, and influence analysis was performed
by omitting each study to find potential outliers [20]. The two
authors inputted the data in the statistic software programs STATA
version11.0toperformthestatisticalanalysisindependentlyandgot
the same results.
Results
Extraction process and study characteristics
With our search criterion, a total of eleven full-text articles [4,9–
15,21–23] were preliminarily identified for further detailed
evaluation (Fig. 1). Two studies that not focused on childhood
ALL risk were excluded after title review. One study [23] was
excluded as another included study [13] was based on the same
population, and one was a systematic review. At last, seven case-
control studies [9–15] were selected, including a total of 880 cases
and 1311 controls originally. A list of characteristics of these
included studies was provided in Table 1. There were 7 studies with
atotalof880casesand1311controlsforArg399Glnpolymorphism,
3 studies with a total of 345 cases and 554 controls for Arg280His
polymorphism, and 6 studies with a total of 783 cases and 1180
controls for Arg194Trp polymorphism. Genotype distributions in
the controls of all studies were in agreement with HWE except one
[13].
Meta-analysis results
Table 2 listed the main results of the meta-analysis. The
results of the associations between XRCC1 Arg399Gln
polymorphism and childhood ALL risk, and the heterogeneity
test were shown in Table 2. When all the eligible studies were
Figure 1. Flowchart of selection of studies for inclusion in
meta-analysis.
doi:10.1371/journal.pone.0034897.g001
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revealed in additive model (OR=1.501, 95% CI 1.112–2.026,
POR=0.008, P=0.384 for heterogeneity)(Fig. 2a). We also found
a significant association with childhood ALL risk in the dominant
model (OR=1.316, 95% CI=1.104–1.569, POR=0.002,
P=0.016 for heterogeneity) (Fig. 2b). No significant association
was found in the recessive model (OR=1.324, 95% CI=0.998–
1.757, P=0.628 for heterogeneity). In subgroup analysis by
ethnicity, the results revealed significant associations between the
XRCC1 Arg399Gln polymorphism and childhood ALL in Asian
population (Additive model: OR=2.338, 95%CI=1.254–4.359,
POR=0.008, P=0.903 for heterogeneity; Dominant model:
OR=2.108, 95%CI=1.498–2.967, POR=0.000 P=0.821 for
heterogeneity). We did not observe any significant association in
any genetic model among other subgroups. Moreover, meta-
regression analysis revealed that ethnicity was a significant source
of between-study heterogeneity (P=0.007).
Table 1. General characteristics of studies included in the meta-analysis.
Author Year Country Ethnicity Source of controls Matching criteria Case Control SNP studied HWE
a
Joseph 2005 India Asian Hospital-based sex, age, ethnicity 117 117 194, 280, 399 Yes
Pakakasama 2007 Thailand Asian Hospital-based ethnicity 108 317 194, 280, 399 Yes
Batar 2009 Turkey Caucasian Hospital-based sex, age, ethnicity 70 75 194, 399 Yes
Meza-Espinoza 2009 Mexico Mestizo Hospital-based ethnicity 120 120 194, 280, 399 Yes
Tumer 2010 Turkey Caucasian Hospital-based ethnicity 167 190 194, 399 Yes
b
Canalle 2011 Brizal Mixed Hospital-based - 201 361 194,399 Yes
Stanczyk 2011 Poland Caucasian Hospital-based ethnicity 97 131 399 Yes
aHWE Hardy–Weinberg equilibrium.
bGenotype distributions of Arg194Trp in the controls were significantly deviated from HWE 399 Arg399Gln, 194 Arg194Trp, 280 Arg280His.
doi:10.1371/journal.pone.0034897.t001
Table 2. Results of the meta-analysis on XRCC1 polymorphisms and childhood ALL risk.
Polymorphism Analysis Case/Control Additive model(aa vs AA)
Dominant model(Aa+aa vs
AA) Recessive model (aa vs AA+Aa)
OR[95% CI] P/Phet OR[95% CI] P/Phet OR[95% CI] P/Phet
Arg399Gln Overall 880/1311 1.501[1.112,
2.026]
0.008/0.384 1.316[1.104,
1.569]
0.002/0.016 1.324[0.998,
1.757]
0.052/0.628
Asian 225/434 2.338[1.254,
4.359]
0.008/0.903 2.108[1.498,
2.967]
0.000/0.821 1.698[0.937,
3.077]
0.081/0.706
Caucasian 334/396 1.289[0.830,
2.000]
0.258/0.168 1.275[0.945,
1.722]
0.112/0.381 1.138[0.760,
1.704]
0.530/0.228
Mestizo 120/120 1.711[0.653,
4.479]
0.274/2 1.306[0.787,
2.169]
0.302/2 1.556[0.612,
3.954]
0.353/2
Mixed 201/361 1.227[0.629,
2.397]
0.548/2 0.845[0.597,
1.194]
0.339/2 1.358[0.707,
2.606]
0.358/2
Arg280His Overall 345/554 1.251[0.371,
4.220]
0.709/0.675 1.125[0.805,
1.574]
0.490/0.534 1.203[0.357,
4.055]
0.765/0.693
Asian 225/434 1.053[0.251,
4.426]
0.944/0.425 1.172[0.774,
1.775]
0.453/0.284 0.989[0.234,
4.175]
0.988/0.461
Mestizo 120/120 2.023[0.180,
22.720]
0.568/2 1.043[0.590,
1.843]
0.885/2 2.017[0.180,
22.545]
0.569/2
Arg194Trp Overall 783/1180 0.806[0.451,
1.438]
0.465/0.041 1.056[0.850,
1.312]
0.625/0.059 0.797[0.445,
1.426]
0.444/0.070
Asian 225/434 0.710[0.319,
1.578]
0.400/0.014 0.966[0.684,
1.363]
0.843/0.007 0.714[0.319,
1.600]
0.414/0.028
Caucasian 237/265 0.585[0.145,
2.351]
0.450/0.056 1.240[0.781,
1.969]
0.361/0.166 0.551[0.136,
2.233]
0.404/0.061
Mestizo 120/120 2.150[0.520,
8.885]
0.290/2 1.265[0.730,
2.190]
0.402/2 2.053[0.501,
8.405]
0.317/2
Mixed 201/361 0.443[0.049,
4.000]
0.469/2 0.929[0.586,
1.474]
0.755/2 0.446[0.050,
4.020]
0.472/2
OR Odds ratio; 95% CI 95% confidence interval.
a:minor allele; A:major allele.
doi:10.1371/journal.pone.0034897.t002
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Arg280His polymorphism (Additive model: OR=1.251, 95%CI
0.371–4.220, POR=0.709; Dominant model: OR=1.125, 95% CI
0.805–1.574, POR=0.490; Recessive model: OR=1.203, 95%CI
0.357–4.055,POR=0.765)andArg194Trppolymorphism(Additive
model: OR=0.806, 95% CI 0.451–1.438, POR=0.465; Dominant
model OR=1.056, 95% CI 0.850–1.312, POR=0.625; Recessive
model=0.797, 95% CI 0.445–1.426, P OR=0.444). Subgroup
analysis based on ethnicity also showed no significant association
between the two SNPs and childhood ALL risk.
Tests of heterogeneity
We have found heterogeneities in four studies: Arg399Gln
polymorphismdominantmodel(p=0.016,I
2=61.6%);Arg194Trp
polymorphism additive model (p=0.041, I
2=56.9%), dominant
model(p=0.059,I
2=53%),recessivemodel(p=0.070,I
2=50.9%)
(Table 2). A random-effects model was employed in these studies.
Sensitivity analysis
Influence analysis was performed to assess the influence of each
individual study on the pooled OR by sequential omission of
individual studies. The results suggested that no individual study
significantly affected the pooled ORs (Fig. 3).
Publication bias
Publication bias was examined by Funnel plot and Egger’s
regression test. The shapes of the funnel plot did not indicate any
evidence of obvious asymmetry in additive model (Fig. 4) and the
Egger’s test suggested the absence of publication bias (P=0.810).
Discussion
XRCC1 plays an important role in the DNA damage repair
pathway for the processing of small base lesions, which has been
thought of as the predominant DNA-damage repair pathway for
the processing of small base lesions derived from oxidation and
alkylation damage [7]. It is widely accepted that alterations in
DNA repair genes play roles in the process associated with the
etiology of cancers. In some of the previous studies, it has been
reported that carriers of the variant allele were at higher risk of
lung cancer [24], breast cancer [25], and prostate cancer among
Asians [26], whereas the result was controversial in gastric cancer
[27], as well as in bladder caner [28]. In this meta-analysis, we
focused on XRCC1 genetic polymorphisms and provide the most
comprehensive assessment of its association with childhood ALL
risk. By critically reviewing 7 studies on XRCC1 Arg399Gln
polymorphism (a total of 880 cases and 1311 controls), 3 studies on
XRCC1 Arg280His polymorphism (a total of 345 cases and 554
controls), and 6 studies on Arg194Trp polymorphism (a total of
783 cases and 1180 controls), we performed a meta-analysis to
indicate that the polymorphisms in XRCC1 Arg399Gln was
significantly associated with risk of childhood ALL. However, we
did not observe associations of XRCC1 Arg280His polymorphism
and Arg194Trp polymorphism with childhood ALL risk.
This study showed that the mean frequency of the XRCC1
variant 399Gln allele was 28.99% (Table S1). Previous investiga-
tions found that the frequency distribution of 399Gln allele
significantly varied in different ethnicities. Among Asian popula-
tion, 22%,28% had at least one copy of the variant allele XRCC1
399Gln [9–10,29–30], while among Caucasian, Turkish, and
other ethnic populations, the frequencies were 28%,43%
[11,13,31–33]. This may lead to XRCC1 Arg399Gln polymor-
phism genotype distribution disequilibrium when all ethnic
populations were pooled together. Ethnicity was significantly
associated with childhood ALL risk and it was considered as a
significant source of heterogeneity in the meta-regression model. It
was essential to conduct a subgroup analysis based on ethnicities.
In this meta-analysis, all subjects were classified into four ethnic
groups (Caucasian, Asian, Metizo and mixed populations). No
association was detected in Caucasians, Metizo and mixed
populations, while increased risk was found in Asian population
carrying variant 399Gln allele homozygote, and it should be
further investigated in large scale Asian populations.
Despite lots of investigations in many aspects of childhood ALL,
little attention has been paid to its pathogenesis, particularly with
respect to genetic susceptibility. Several reports have demonstrated
the association between some DNA repair gene variants and
childhoodALL,sothepossiblerelationshipbetweenpolymorphisms
of DNA repair genes and childhood ALL may be helpful in
understanding the pathogenesis of childhood ALL and the
prevention of this disease. Our results suggest that the risk of
childhood ALL may be associated with DNA repair mechanisms.
Figure 2. Meta-analysis of XRCC1 Arg399Gln polymorphism in childhood ALL. a Additive model, b Dominant model.
doi:10.1371/journal.pone.0034897.g002
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factor,andethnicbackgroundmighthaveanimpactontheresultsin
thestudiesofitspolymorphismsinchildhoodALL.Analysisofthese
polymorphisms,particularlyXRCC1codon399Arg/Glnmayhelp
inidentifyingindividualsatriskofdevelopingALLandprovidingan
essential information source for future improvement of ALL
treatment.
Although our result is suggestive, there are still some limitations
in this meta-analysis. First, heterogeneity among the studies,
resulting from different sources of controls, matching criteria of
age and gender or some other factors, may influence the results of
this analysis. The matching criteria of the control group, such as
age, gender, and environment exposures, are different between
studies. Furthermore, childhood ALL is heterogeneous considering
its underlying cellular and molecular biology, so subtypes of B- or
T-cell precursor ALL may not be suspected to share a common
etiology. To date none of the studies have examined the
relationship between XRCC1 variants and risk by subtype. Second,
specific environmental and lifestyle factors may alter those
associations between gene polymorphisms and cancer risk.
Figure 3. Influence analysis for AA versus GG in the overall meta-analysis. This figure shows the influence of individual studies on the
summary OR. The middle vertical axis indicates the overall OR and the two vertical axes indicate its 95% CI. Open circles indicate the pooled OR when
the left study is omitted in this meta-analysis. The two ends of the dotted lines represent the 95% CI.
doi:10.1371/journal.pone.0034897.g003
Figure 4. Funnel plot of XRCC1 Arg399Gln polymorphism and childhood ALL risk for publication bias.
doi:10.1371/journal.pone.0034897.g004
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PLoS ONE | www.plosone.org 5 April 2012 | Volume 7 | Issue 4 | e34897Evidence supports that there is no association between Gln/Gln
genotype of Arg399Gln and bladder cancer risk in total
population, but it is associated with a decreased risk of bladder
cancer among ever smokers [34,35]. The relationship between
XRCC1 gene polymorphism and childhood ALL risk was analyzed
without consideration of gene–gene and gene-environment
interactions because of the lack of sufficient data, which should
be further investigated. Third, the Funnel plot did not reveal any
evidence of obvious publication bias, while there is still a possibility
that our meta-analysis was biased toward a positive result since
negative findings were likely to be unreported.
In summary, it is a worthy and meaningful enterprise to search
for polymorphic variants influencing the risk of childhood ALL.
This meta-analysis suggests that XRCC1 399Gln might be a
susceptibility allele for childhood ALL. However, we could not
observe any association of XRCC1 Arg194Trp and Arg280His
with childhood ALL. We have searched as many publications as
we could by means of various searching approaches, comprehen-
sively assessed publication biases and pinpointed the potential
sources of heterogeneity via subgroup and sensitivity analysis.
However, these results may be biased by the relatively small
number of subjects, and therefore need to be validated by larger
studies and subsequent update of the current meta-analysis. In
order to understand the mechanisms underlying childhood ALL
better, future research should be considered and investigated.
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